ADC Therapeutics (ADCT)
(Delayed Data from NYSE)
$4.97 USD
+0.29 (6.20%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $4.96 -0.01 (-0.20%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.58 | 4.00% |
Earnings Summary
For their last quarter, ADC Therapeutics (ADCT) reported earnings of -$1.03 per share, missing the Zacks Consensus Estimate of -$0.47 per share. This reflects a negative earnings surprise of 119.15%. Look out for ADCT's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.58 per share, reflecting a year-over-year increase of 21.62%.
Earnings History
Price & Consensus
Zacks News for ADCT
Adobe (ADBE) to Report Q1 Earnings: What's in the Offing?
ADCT: What are Zacks experts saying now?
Zacks Private Portfolio Services